Hong Kong Genome Institute

The Hong Kong Genome Institute (HKGI), established and wholly owned by the Hong Kong SAR Government, commenced full operations in 2021. With the vision to avail genomic medicine to all for better health and well-being and supported by the Health Bureau, HKGI works in close collaboration with the Department of Health, Hospital Authority, medical schools of local universities and other stakeholders to accelerate the development of genomic medicine in Hong Kong along four strategic foci: integrate genomics into medicine, advance research, nurture talents and enhance public genomic literacy. www.hkgp.org | enquiry@genomics.org.hk

Genomics,next generation sequencing,health services,bioinformatics,whole genome sequencing,data science,rare disease,genomic healthcare,clinical data,real world evidence,human genetics,genomic medicine,hereditary cancer,precision health,research,undiagnosed disease,and diagnostics

Hong kong genome institute operates in the Biotechnology research industry.

Hong kong genome institute's revenue is 11m - 100m

Hong kong genome institute has 11 - 50 employees.